Metabolomics of Therapy Response in Preclinical Glioblastoma: A Multi-Slice MRSI-Based Volumetric Analysis for Noninvasive Assessment of Temozolomide Treatment

Glioblastoma (GBM) is the most common aggressive primary brain tumor in adults, with a short survival time even after aggressive therapy. Non-invasive surrogate biomarkers of therapy response may be relevant for improving patient survival. Previous work produced such biomarkers in preclinical GBM us...

Full description

Saved in:
Bibliographic Details
Published in:Metabolites
Main Authors: Arias-Ramos, Nuria, Ferrer-Font, Laura, Lope-Piedrafita, Silvia, Mocioiu, Victor, Julià-Sapé, Margarida, Pumarola, Martí, Arús, Carles, Candiota, Ana Paula
Format: Artigo
Language:Inglês
Published: MDPI 2017
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5487991/
https://ncbi.nlm.nih.gov/pubmed/28524099
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/metabo7020020
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items